185 related articles for article (PubMed ID: 10226867)
21. Aliskiren reduces myocardial ischemia-reperfusion injury by a bradykinin B2 receptor- and angiotensin AT2 receptor-mediated mechanism.
Koid SS; Ziogas J; Campbell DJ
Hypertension; 2014 Apr; 63(4):768-73. PubMed ID: 24420538
[TBL] [Abstract][Full Text] [Related]
22. Postischemic antiarrhythmic effects of angiotensin-converting enzyme inhibitors. Role of suppression of endogenous endothelin secretion.
Brunner F; Kukovetz WR
Circulation; 1996 Oct; 94(7):1752-61. PubMed ID: 8840871
[TBL] [Abstract][Full Text] [Related]
23. Differential effects of short-term ace- and AT1-receptor inhibition on postischemic injury and leukocyte adherence in vivo and in vitro.
Guba M; Steinbauer M; Büchner M; Frölich D; Farkas S; Jauch KW; Anthuber M
Shock; 2000 Mar; 13(3):190-6. PubMed ID: 10718375
[TBL] [Abstract][Full Text] [Related]
24. Beneficial effects of angiotensin I converting enzyme inhibitor on post-ischemic contractile function of perfused rat heart.
Tanonaka K; Kamiyama T; Takezono A; Sakai K; Takeo S
J Mol Cell Cardiol; 1996 Aug; 28(8):1659-70. PubMed ID: 8877776
[TBL] [Abstract][Full Text] [Related]
25. Use of losartan to examine the role of the cardiac renin-angiotensin system in myocardial dysfunction during ischemia and reperfusion.
Werrmann JG; Cohen SM
J Cardiovasc Pharmacol; 1996 Feb; 27(2):177-82. PubMed ID: 8720414
[TBL] [Abstract][Full Text] [Related]
26. Cardioprotective effects of propofol and sevoflurane in ischemic and reperfused rat hearts: role of K(ATP) channels and interaction with the sodium-hydrogen exchange inhibitor HOE 642 (cariporide).
Mathur S; Farhangkhgoee P; Karmazyn M
Anesthesiology; 1999 Nov; 91(5):1349-60. PubMed ID: 10551586
[TBL] [Abstract][Full Text] [Related]
27. Postischemic apoptosis and functional recovery after angiotensin II type 1 receptor blockade in isolated working rat hearts.
Moudgil R; Menon V; Xu Y; Musat-Marcu S; Kumar D; Jugdutt BI
J Hypertens; 2001 Jun; 19(6):1121-9. PubMed ID: 11403362
[TBL] [Abstract][Full Text] [Related]
28. Protective effect of the specific endothelin-1 antagonist BQ610 on mechanical function and energy metabolism during ischemia/reperfusion injury in isolated perfused rat hearts.
Illing B; Horn M; Han H; Hahn S; Bureik P; Ertl G; Neubauer S
J Cardiovasc Pharmacol; 1996 Apr; 27(4):487-94. PubMed ID: 8847864
[TBL] [Abstract][Full Text] [Related]
29. Effects of captopril and losartan on myocardial ischemia-reperfusion induced arrhythmias and necrosis in rats.
Ozer MK; Sahna E; Birincioglu M; Acet A
Pharmacol Res; 2002 Apr; 45(4):257-63. PubMed ID: 12030787
[TBL] [Abstract][Full Text] [Related]
30. Effects of the angiotensin AT1 receptor blocker candesartan on myocardial ischemic/reperfusion injury.
Shimizu M; Sjöquist PO; Wang QD; Rydén L
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S137-42. PubMed ID: 9892154
[TBL] [Abstract][Full Text] [Related]
31. Effect of angiotensin converting enzyme inhibitor and angiotensin II type 1 receptor antagonist on metabolism and contraction in ischemia-reperfused rabbit heart.
Kawabata H; Ryomoto T; Ishikawa K
Jpn Circ J; 2000 Apr; 64(4):276-82. PubMed ID: 10783050
[TBL] [Abstract][Full Text] [Related]
32. Tissue kallikrein is involved in the cardioprotective effect of AT1-receptor blockade in acute myocardial ischemia.
Messadi-Laribi E; Griol-Charhbili V; Pizard A; Vincent MP; Heudes D; Meneton P; Alhenc-Gelas F; Richer C
J Pharmacol Exp Ther; 2007 Oct; 323(1):210-6. PubMed ID: 17636004
[TBL] [Abstract][Full Text] [Related]
33. Angiotensin-converting enzyme inhibition in infarct-induced heart failure in rats: bradykinin versus angiotensin II.
Stauss HM; Zhu YC; Redlich T; Adamiak D; Mott A; Kregel KC; Unger T
J Cardiovasc Risk; 1994 Oct; 1(3):255-62. PubMed ID: 7621306
[TBL] [Abstract][Full Text] [Related]
34. Participation of angiotensin II and bradykinin in contractile function in dog stunned myocardium.
Nakai T; Satoh K; Kosugi T; Hoshi K; Ichihara K
Eur J Pharmacol; 1999 Oct; 382(3):187-96. PubMed ID: 10556669
[TBL] [Abstract][Full Text] [Related]
35. Paracrine systems in the cardioprotective effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury in rats.
Liu YH; Yang XP; Sharov VG; Sigmon DH; Sabbath HN; Carretero OA
Hypertension; 1996 Jan; 27(1):7-13. PubMed ID: 8591891
[TBL] [Abstract][Full Text] [Related]
36. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers synergistically increase coronary blood flow in canine ischemic myocardium: role of bradykinin.
Kitakaze M; Asanuma H; Funaya H; Node K; Takashima S; Sanada S; Asakura M; Ogita H; Kim J; Hori M
J Am Coll Cardiol; 2002 Jul; 40(1):162-6. PubMed ID: 12103271
[TBL] [Abstract][Full Text] [Related]
37. Influence of local converting enzyme inhibition on angiotensin and bradykinin effects in ischemic rat hearts.
Linz W; Schölkens BA
J Cardiovasc Pharmacol; 1987; 10 Suppl 7():S75-82. PubMed ID: 2485067
[TBL] [Abstract][Full Text] [Related]
38. Angiotensin II activates NADPH oxidase in isolated rat hearts subjected to ischaemia-reperfusion.
Oudot A; Vergely C; Ecarnot-Laubriet A; Rochette L
Eur J Pharmacol; 2003 Feb; 462(1-3):145-54. PubMed ID: 12591107
[TBL] [Abstract][Full Text] [Related]
39. Protection against injury during ischemia and reperfusion by acadesine derivatives GP-1-468 and GP-1-668. Studies in the transplanted rat heart.
Galiñanes M; Zhai X; Bullough D; Mullane KM; Hearse DJ
J Thorac Cardiovasc Surg; 1995 Sep; 110(3):752-61. PubMed ID: 7564443
[TBL] [Abstract][Full Text] [Related]
40. AT1 and aldosterone receptors blockade prevents the chronic effect of nandrolone on the exercise-induced cardioprotection in perfused rat heart subjected to ischemia and reperfusion.
Marques-Neto SR; Ferraz EB; Rodrigues DC; Njaine B; Rondinelli E; Campos de Carvalho AC; Nascimento JH
Cardiovasc Drugs Ther; 2014 Apr; 28(2):125-35. PubMed ID: 24258356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
